Showcases Stock ranks Forex

Pfizer Inc (PFE)
43.16  0.3 (0.7%) 10-22 16:02
Open: 42.82 Pre. Close: 42.86
High: 43.19 Low: 42.63
Volume: 17,151,450 Market Cap: 241,985M
Pfizer Inc. develops, manufactures, and sells healthcare products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and pain under the Eliquis, Chantix/Champix, and Premarin family brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Sutent, Xtandi, Xalkori, Inlyta, Braftovi + Mektovi brands; and sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Vfend, and Zithromax brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, and tick-borne encephalitis under the Prevnar 13/Prevenar 13 (pediatric/adult), FSME-IMMUN, Nimenrix, and Trumenba brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, and Eucrisa brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, Genotropin, and Refacto AF/Xyntha brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration and/or co-promotion agreements with Bristol-Myers Squibb Company and Astellas Pharma US, Inc.; a licensing agreement with Akcea Therapeutics, Inc; a strategic alliance with Verily Life Sciences LLC; collaboration agreements with Merck KGaA and Valneva SE; a clinical trial collaboration and supply agreement with IDEAYA Biosciences, Inc.; a material transfer and collaboration agreement with BioNTech SE; a clinical supply collaboration with Jiangsu Alphamab Biopharmaceuticals Co., Ltd; a research collaboration and license agreement with BioInvent International AB; and a multi-target drug discovery collaboration with Sosei Group Corporation. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Prices Prediction (Update @5:00pm)
If tomorrow: Open lower Open higher
High: 43.194 - 43.345 43.345 - 43.482
Low: 42.191 - 42.387 42.387 - 42.567
Close: 42.849 - 43.123 43.123 - 43.373
Stock Technical Analysis
Target: Six months: 52.24
One year: 61.02
Support: Support1: 42.39
Support2: 40.94
Resistance: Resistance1: 44.73
Resistance2: 52.24
Pivot: 42.18
Moving Averages: MA(5): 42.45
MA(20): 42.44
MA(100): 42.98
MA(250): 39.37
MACD: MACD(12,26): -0.52
Signal(12,26,9): -0.74
%K %D: %K(14,3): 77.20
%D(3): 57.45
RSI: RSI(14): 51.70
52-Week: High: 51.86
Low: 32.827324
Change(%): 20.0
Average Vol(K): 3-Month: 3207586
10-Days: 1979224
Price, MAs and Bollinger Bands
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.

PFE has closed below upper band by 5.1%. Bollinger Bands are 41.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to PFE's normal range. The bands have been in this narrow range for 2 bars. This is a sign that the market may be about to initiate a new trend.
Stock chart
Stock News
Fri, 22 Oct 2021
Fastly, PagerDuty, Johnson & Johnson, Moderna and Pfizer highlighted as Zacks Bull and Bear of the Day - Yahoo Finance

Fri, 22 Oct 2021
Pfizer Says Covid Vaccine 91% Effective in Kids Ages 5 to 11 - Bloomberg

Thu, 21 Oct 2021
BioNTech SE (BNTX) and Pfizer Inc. (PFE) Announce Phase 3 Trial Data for Covid-19 Booster; Shares Mixed - InvestorsObserver

Mon, 11 Oct 2021
Is Pfizer (NYSE:PFE) A Risky Investment? - Simply Wall St

Thu, 07 Oct 2021
Pfizer Inc. (PFE) is lower by -0.47% in a Week, Should You Buy? - InvestorsObserver

Tue, 05 Oct 2021
Is Pfizer Inc. (PFE) Stock Trading Below Fair Value? - InvestorsObserver

Financial Analysis
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company's ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Stock Basics & Statistics
Exchange:  New York Stock Exchange
Sector:  Healthcare
Industry:  Drug Manufacturers—General
Shares Out. (M) 5600.00
Shares Float (M) 5590.00
% Held by Insiders 0.04
% Held by Institutions 66.60
Shares Short (K) 59770
Shares Short Prior Month (K) 57320
Stock Financials
EPS 1.970
Book Value (p.s.) 12.270
Profit Margin 24.00
Operating Margin 25.80
Return on Assets (ttm) 4.6
Return on Equity (ttm) 14.0
Qtrly Rev. Growth 44.6
Gross Profit (p.s.) 5.952
Sales Per Share 8.288
EBITDA (p.s.) 3.004
Qtrly Earnings Growth 45.40
Operating Cash Flow (M) 15810.00
Levered Free Cash Flow (M) 12380.00
Stock Valuation
PE Ratio 21.91
PEG Ratio
Price to Book value 3.52
Price to Sales 5.21
Price to Cash Flow 15.29
Stock Dividends
Dividend 1.530
Dividend Yield 0.04
Dividend Growth 1.560

Stoxline Lite

Stoxline Pro

Stock Chart

Option Calculator